CellResearch Corporation
PrivateLast Round
Grant
Oct 13, 2021
Est. Valuation
$518M
Total Funding Raised
$14.8M
Company Overview
CellResearch Corporation operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Grant round in October 2021.
CellResearch Corporation is a biotechnology company that develops stem-cell-based research products and regenerative therapies derived from umbilical cord lining.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellResearch Corporation Comparables
Compare CellResearch Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cynata Therapeutics Limited | 77% | |
| ExoCoBio | 75% | |
| Rion Aesthetics | 74% |
For institutional investors. Book with your work email.
CellResearch Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 13, 2021 | ||||
| Convertible Debt | Feb 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CellResearch Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of Singapore | Grant |
| A*STAR | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2023
Grew 18% QoQ, from 17 to 20 employees.
- Oct 13, 2021
Secured $12M from A*STAR and Government of Singapore.
For institutional investors. Book with your work email.
CellResearch Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellResearch Corporation's valuation, stock price, and market status.
Is CellResearch Corporation a public or private company?
CellResearch Corporation is a private company.
What is the current stock price of CellResearch Corporation?
CellResearch Corporation is a private company, so its shares have no public market price. Caplight tracks CellResearch Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellResearch Corporation worth (valuation)?
CellResearch Corporation's valuation is estimated at $518.0M based on funding round data.
Can I buy CellResearch Corporation stock?
CellResearch Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellResearch Corporation's last funding round?
CellResearch Corporation's most recent funding round was Grant on October 13, 2021.
Who are the main investors in CellResearch Corporation?
Key investors in CellResearch Corporation include Government of Singapore, A*STAR.
Will CellResearch Corporation IPO soon?
No public IPO plans have been announced for CellResearch Corporation.
How can I track CellResearch Corporation secondary market activity?
Caplight tracks bids, offers, and trades in CellResearch Corporation's shares on secondary markets.